How does cancer immunotherapy work?

The immune system will discover and protect the body from infections and diseases. Cancer is a complicated disease that can bypass the immune system and transcend. Usually it will not be recognized until handling becomes difficult.

Cancer immunotherapy can improve the ability of the immune system to eliminate cancer. There are several kinds of immunotherapy, each of which helps the immune system in various ways.

Immunocheckpoint treatment helps anticancer immune cells (called T cells) to develop more durable responses to cancer

Adoptive cell therapy increases the number and / or efficacy of immune cells (typically T cells), which increases the ability to respond to immune responses to cancer. There are three main types of adoptive cell therapy.

Chimeric antigen receptor (CAR) T cell therapy provides patients with a large number of genetically engineered T cells to detect and fight cancer

Tumor infiltrating lymphocyte (TIL) therapy uses T cells from patients collected from surgically resected tumors. These cells may recognize cancer, but they are too few to succeed. The number of these cells increases significantly in the laboratory and is then returned to the patient

Endogenous T cell (ETC) therapy uses T cells from the patient's blood. From this diverse pool of T cells, the physician selects only cells that recognize cancer-specific features. The number of these particular T cells increases considerably and is then returned to the patient

Cancer vaccines help the body recognize cancer cells and stimulate the immune system to destroy them. Cancer vaccines usually include one of the following:

Monoclonal antibodies bind to specific proteins on the surface of cancer cells or immune cells. which one:

Cytokine therapy relies on proteins called interferons and interleukins to elicit an immune response. Interleukin-2 (IL-2) is used to treat kidney cancer and melanoma spreading to other parts of the body. Interferon alpha (IFN-alpha) is currently used to treat melanoma, kidney cancer and certain leukemias and lymphomas. These cytokine therapies are combined with other types of immunotherapy to increase their effectiveness.

There are serious side effects for each type of immunotherapy. In addition, certain immunotherapies are more effective than certain other types of cancer. The overall health condition of the patient and the type of cancer determine the available immunotherapy.

Two types of immunotherapy may be used in combination during treatment. In other cases, a single immunotherapy is used with another type of therapy such as chemotherapy. These combination methods are used to improve treatment

While other immunotherapies are provided only through clinical trials, some immunotherapies are standard therapies for specific cancers. Current immunotherapy can not treat certain cancers. To expand the benefits of immunotherapy, MD Anderson is leading research to identify new and more effective ways to improve the immune response to cancer.

Maysoun itself does not pay close attention to immunotherapy research - it focuses on other targeted therapies - but she recently made it possible for immunotherapy to eliminate the possibility of cancer in the patient I pointed out. Indeed, more than 240 immunotherapy drugs and vaccines are currently being developed, and these drugs and vaccines have brought great hope for cancer patients worldwide. "Targeted therapy allows other patients, especially breast cancer patients, to lengthen their lives in meaningful ways," Maysoun says. "There is no doubt that an immunotherapy that is likely to cure cancer is under development, while these patients have a longer lifespan and a healthier lifespan."

Cancer immunotherapy is a therapy for treating cancer patients who are involved in or use the immune system's components. Some cancer immunotherapies consist of antibodies that bind to proteins expressed by cancer cells and inhibit their function. Other cancer immunotherapies include vaccines and T cell injection

The most exciting thing is immunotherapy, a new approach that appeared in the past few years. The human immune system has a set of brakes on which cancer cells can be activated; the first immunotherapy treatment effectively blocks the brakes, allowing the white blood cells to attack the tumor. It is still in its early stages, but in a small number of patients the long-term relief from this mechanism is equivalent to treatment. More than 1,000 clinical trials of this type of treatment are currently under way for various cancers. It is now possible to reprogram immune cells by editing the genome to better fight cancer and such initial gene therapy was approved for use in the United States last month.